vs
ASTROTECH Corp（ASTC）与因美纳（ILMN）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是ASTROTECH Corp的7459.5倍（$1.1B vs $148.0K）。因美纳净利率更高（16.8% vs -2653.4%，领先2670.2%）。因美纳同比增速更快（-1.6% vs -43.3%）。因美纳自由现金流更多（$335.0M vs $-4.0M）。过去两年ASTROTECH Corp的营收复合增速更高（72.0% vs 0.8%）
航天科技公司（原名Spacehab Inc.）是一家总部位于美国得克萨斯州奥斯汀的科技孵化企业。该公司整合内部、研究机构、政府实验室及高校的技术资源，投资、孵化并退出初创企业，旗下子公司还为美国航空航天局、美国国防部、各国航天机构及全球商业客户提供商业化产品与服务。
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
ASTC vs ILMN — 直观对比
营收规模更大
ILMN
是对方的7459.5倍
$148.0K
营收增速更快
ILMN
高出41.7%
-43.3%
净利率更高
ILMN
高出2670.2%
-2653.4%
自由现金流更多
ILMN
多$339.0M
$-4.0M
两年增速更快
ASTC
近两年复合增速
0.8%
损益表 — Q2 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $148.0K | $1.1B |
| 净利润 | $-3.9M | $186.0M |
| 毛利率 | 5.4% | 65.9% |
| 营业利润率 | -2635.8% | 15.8% |
| 净利率 | -2653.4% | 16.8% |
| 营收同比 | -43.3% | -1.6% |
| 净利润同比 | 2.0% | 205.7% |
| 每股收益（稀释后） | — | $1.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTCILMN
| Q4 25 | $148.0K | — | ||
| Q3 25 | $297.0K | — | ||
| Q2 25 | $220.0K | — | ||
| Q1 25 | $534.0K | — | ||
| Q4 24 | $261.0K | $1.1B | ||
| Q3 24 | $34.0K | $1.1B | ||
| Q2 24 | $74.0K | $1.1B | ||
| Q1 24 | $50.0K | $1.1B |
净利润ASTCILMN
| Q4 25 | $-3.9M | — | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $-3.6M | — | ||
| Q4 24 | $-4.0M | $186.0M | ||
| Q3 24 | $-3.3M | $705.0M | ||
| Q2 24 | $-3.0M | $-2.0B | ||
| Q1 24 | $-3.2M | $-126.0M |
毛利率ASTCILMN
| Q4 25 | 5.4% | — | ||
| Q3 25 | 63.3% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 59.4% | 65.9% | ||
| Q3 24 | 26.5% | 69.0% | ||
| Q2 24 | 37.8% | 64.8% | ||
| Q1 24 | 16.0% | 62.0% |
营业利润率ASTCILMN
| Q4 25 | -2635.8% | — | ||
| Q3 25 | -1190.6% | — | ||
| Q2 25 | -1326.4% | — | ||
| Q1 25 | -724.2% | — | ||
| Q4 24 | -1655.6% | 15.8% | ||
| Q3 24 | -10670.6% | 68.6% | ||
| Q2 24 | -4518.9% | -147.2% | ||
| Q1 24 | -7066.0% | -10.3% |
净利率ASTCILMN
| Q4 25 | -2653.4% | — | ||
| Q3 25 | -1166.7% | — | ||
| Q2 25 | -1331.8% | — | ||
| Q1 25 | -680.3% | — | ||
| Q4 24 | -1536.0% | 16.8% | ||
| Q3 24 | -9641.2% | 65.3% | ||
| Q2 24 | -3998.6% | -178.8% | ||
| Q1 24 | -6308.0% | -11.7% |
每股收益（稀释后）ASTCILMN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.16 | ||
| Q3 24 | — | $4.42 | ||
| Q2 24 | — | $-12.48 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.0M | $93.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.5M | $2.4B |
| 总资产 | $19.7M | $6.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTCILMN
| Q4 25 | $7.0M | — | ||
| Q3 25 | $11.3M | — | ||
| Q2 25 | $15.1M | — | ||
| Q1 25 | $18.1M | — | ||
| Q4 24 | $21.5M | $93.0M | ||
| Q3 24 | $21.8M | $70.0M | ||
| Q2 24 | $42.9M | $74.0M | ||
| Q1 24 | $52.4M | — |
股东权益ASTCILMN
| Q4 25 | $15.5M | — | ||
| Q3 25 | $19.1M | — | ||
| Q2 25 | $22.1M | — | ||
| Q1 25 | $24.8M | — | ||
| Q4 24 | $28.1M | $2.4B | ||
| Q3 24 | $32.1M | $2.1B | ||
| Q2 24 | $34.8M | $1.4B | ||
| Q1 24 | $37.6M | $5.7B |
总资产ASTCILMN
| Q4 25 | $19.7M | — | ||
| Q3 25 | $23.2M | — | ||
| Q2 25 | $27.0M | — | ||
| Q1 25 | $27.5M | — | ||
| Q4 24 | $31.0M | $6.3B | ||
| Q3 24 | $34.4M | $6.0B | ||
| Q2 24 | $37.6M | $6.1B | ||
| Q1 24 | $40.2M | $10.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.5M | $364.0M |
| 自由现金流经营现金流 - 资本支出 | $-4.0M | $335.0M |
| 自由现金流率自由现金流/营收 | -2671.6% | 30.3% |
| 资本支出强度资本支出/营收 | 277.7% | 2.6% |
| 现金转化率经营现金流/净利润 | — | 1.96× |
| 过去12个月自由现金流最近4个季度 | $-14.9M | $709.0M |
8季度趋势，按日历期对齐
经营现金流ASTCILMN
| Q4 25 | $-3.5M | — | ||
| Q3 25 | $-3.9M | — | ||
| Q2 25 | $-2.4M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $-3.0M | $364.0M | ||
| Q3 24 | $-3.7M | $316.0M | ||
| Q2 24 | $-2.5M | $80.0M | ||
| Q1 24 | $-2.3M | $77.0M |
自由现金流ASTCILMN
| Q4 25 | $-4.0M | — | ||
| Q3 25 | $-4.4M | — | ||
| Q2 25 | $-2.7M | — | ||
| Q1 25 | $-3.9M | — | ||
| Q4 24 | $-3.4M | $335.0M | ||
| Q3 24 | $-3.9M | $284.0M | ||
| Q2 24 | $-2.8M | $49.0M | ||
| Q1 24 | $-2.5M | $41.0M |
自由现金流率ASTCILMN
| Q4 25 | -2671.6% | — | ||
| Q3 25 | -1476.1% | — | ||
| Q2 25 | -1231.4% | — | ||
| Q1 25 | -728.1% | — | ||
| Q4 24 | -1288.5% | 30.3% | ||
| Q3 24 | -11408.8% | 26.3% | ||
| Q2 24 | -3728.4% | 4.4% | ||
| Q1 24 | -5036.0% | 3.8% |
资本支出强度ASTCILMN
| Q4 25 | 277.7% | — | ||
| Q3 25 | 150.8% | — | ||
| Q2 25 | 158.2% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 122.2% | 2.6% | ||
| Q3 24 | 567.6% | 3.0% | ||
| Q2 24 | 305.4% | 2.8% | ||
| Q1 24 | 352.0% | 3.3% |
现金转化率ASTCILMN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTC
暂无分部数据
ILMN
| Sequencing | $1.0B | 91% |
| Microarray | $101.0M | 9% |
| Investee | $7.0M | 1% |
